loading...| Preferred Name |
Cefotetan |
|
| Synonyms |
Disodium Salt, Cefotetan |
|
| Definitions |
A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D015313 |
|
| altLabel |
Disodium Salt, Cefotetan Cefotetan Disodium Salt Apatef Disodium, Cefotetan ICI 156834 YM 09330 ICI156834 YM-09330 Cefotetan Disodium Ceftotan YM09330 Apacef Salt, Cefotetan Disodium ICI-156834 Cefotan 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))- |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0007555 C1564558 C1564559 C0700471 C0020759 C0733425 C0007553 |
|
| DC |
1 |
|
| definition |
A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. |
|
| DX |
19890101 |
|
| HN |
89 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
0GXP746VXB 48SPP0PA9Q 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
89 |
|
| MDA |
19880531 |
|
| MMR |
20170524 |
|
| MN |
D02.065.589.099.249.250.199 D03.383.129.617.235 D02.886.665.074.250.199 D03.633.100.300.249.250.199 |
|
| notation |
D015313 |
|
| PA |
D000900 |
|
| prefLabel |
Cefotetan |
|
| RR |
0GXP746VXB 69712-56-7 (Cefotetan) 74356-00-6 (di-Na salt) |
|
| TERMUI |
T045037 T045034 T622959 T359721 T045033 T045035 T045032 T622957 T045036 |
|
| TH |
US NLM (1999) NLM (2005) CA NLM (1990) FDA SRS (2014) UNK (19XX) INN (19XX) AU USP (19XX) BAN (19XX) FR USAN (1983) |
|
| tui |
T109 T195 |
|
| subClassOf |